المؤلفون: Cuervo-Arango, Ignacio, Pérez-Santamarina, Rafael, Poveda, José Luís, Romero, José Antonio, Santamaría Ortiz, Amparo, Álvarez Román, María Teresa

المساهمون: Álvarez-Román MT, Pérez-Santamarina R, Romero JA Hospital Universitario La Paz, Madrid, Spain. Cuervo-Arango I Hoffmann-La Roche Ltd, Madrid, Spain. Poveda JL Hospital Universitario La Fe, Valencia, Spain. Santamaría A Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Hemofília, Medicaments - Eficàcia, Equips d'especialistes - Espanya, DISEASES::Hemic and Lymphatic Diseases::Hematologic Diseases::Blood Coagulation Disorders::Blood Coagulation Disorders, Inherited::Hemophilia A, PUBLIC HEALTH::Epidemiology and Biostatistics::Epidemiology::Uses of Epidemiology::Efficacy, PSYCHIATRY AND PSYCHOLOGY::Psychological Phenomena::Mental Processes::Thinking::Problem Solving::Decision Making, Shared, GEOGRAPHICALS::Geographic Locations::Europe::Spain, ENFERMEDADES::enfermedades hematológicas y linfáticas::enfermedades hematológicas::trastornos de la coagulación sanguínea::trastornos de la coagulación sanguínea hereditarios::hemofilia A, SALUD PÚBLICA::epidemiología y bioestadística::epidemiología::usos de la epidemiología::eficacia, PSIQUIATRÍA Y PSICOLOGÍA::fenómenos psicológicos::procesos mentales::pensamiento::toma de decisión, DENOMINACIONES GEOGRÁFICAS::Ubicaciones Geográficas::Europa (Continente)::España

وصف الملف: application/pdf

العلاقة: Global Health & Technology Assessment;6(1); https://journals.aboutscience.eu/index.php/grhta/article/view/452Test; Álvarez-Román MT, Cuervo-Arango I, Pérez-Santamarina R, Luís Poveda J, Romero JA, Santamaría A, et al. Determining the value contribution of emicizumab (Hemlibra ®) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis. Glob Reg Heal Technol Assess. 2019 Oct 8;6(1):1–8.; https://hdl.handle.net/11351/5216Test; 000489225800001

الإتاحة: https://doi.org/10.1177/2284240319880534Test
https://hdl.handle.net/11351/5216Test

المؤلفون: Jose Villar, Constanza P Soto Conti, Robert B Gunier, Shabina Ariff, Rachel Craik, Paolo I Cavoretto, Stephen Rauch, Serena Gandino, Ricardo Nieto, Adele Winsey, Camilla Menis, Gabriel B Rodriguez, Valeria Savasi, Niyazi Tug, Sonia Deantoni, Marta Fabre, Begoña Martinez de Tejada, Maria Jose Rodriguez-Sibaja, Stefania Livio, Raffaele Napolitano, Nerea Maiz, Helena Sobrero, Ashley Peterson, Philippe Deruelle, Carolina Giudice, Jagjit S Teji, Roberto A Casale, Laurent J Salomon, Federico Prefumo, Leila Cheikh Ismail, Michael G Gravett, Marynéa Vale, Valeria Hernández, Loïc Sentilhes, Sarah R Easter, Carola Capelli, Emily Marler, Daniela M Cáceres, Guadalupe Albornoz Crespo, Ernawati Ernawati, Michal Lipschuetz, Ken Takahashi, Carmen Vecchiarelli, Teresa Hubka, Satoru Ikenoue, Gabriela Tavchioska, Babagana Bako, Adejumoke I Ayede, Brenda Eskenazi, Jim G Thornton, Zulfiqar A Bhutta, Stephen H Kennedy, Aris T Papageorghiou

المساهمون: Institut Català de la Salut, [Villar J] Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, UK. Oxford Maternal and Perinatal Health Institute, Green Templeton College, University of Oxford, Oxford, UK. [Soto Conti CP] Division Neonatología, Hospital Materno Infantil Ramón Sarda, Buenos Aires, Argentina. [Gunier RB] Center for Environmental Research and Community Health (CERCH), School of Public Health, University of California, Berkeley, CA, USA. [Ariff S] Department of Paediatrics and Child Health, The Aga Khan University Hospital, Karachi, Pakistan. [Craik R] Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford, UK. [Cavoretto PI] Vita-Salute San Raffaele University and IRCCS San Raffaele Scientific Institute, Obstetrics and Gynaecology Department, Milan, Italy. [Maiz N] Unitat de Medicina Fetal, Unitat Docent d’Obstetrícia i Ginecologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Complex Mixtures::Biological Products::Vaccines [CHEMICALS AND DRUGS], diagnóstico::pronóstico::resultado del embarazo [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Embaràs, Medicaments - Eficàcia, virosis::infecciones por virus ARN::infecciones por Nidovirales::infecciones por Coronaviridae::infecciones por Coronavirus [ENFERMEDADES], Virus Diseases::RNA Virus Infections::Nidovirales Infections::Coronaviridae Infections::Coronavirus Infections [DISEASES], General Medicine, Diagnosis::Prognosis::Pregnancy Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], COVID-19 (Malaltia) - Vacunació, mezclas complejas::productos biológicos::vacunas [COMPUESTOS QUÍMICOS Y DROGAS]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d42d1ae99eb15c32e459639c1105600Test
https://hdl.handle.net/11379/568690Test

المؤلفون: Albert Manzano-Muñoz, José Yeste, María A. Ortega, Fernando Martín, Anna López, Jordi Rosell, Sandra Castro, César Serrano, Josep Samitier, Javier Ramón-Azcón, Joan Montero

المساهمون: Institut Català de la Salut, [Manzano-Muñoz A] Nanobioengineering Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. [Yeste J, López A] Biosensors for Bioengineering Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. [Ortega MA] Biosensors for Bioengineering Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. Vitala Technologies, Barcelona, Spain. [Martín F] Nanobioengineering Group, Institute for Bioengineering of Catalonia (IBEC), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain. Networking Biomedical Research Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain. [Rosell J] Sarcoma Translational Research Program, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Castro S] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Serrano C] Sarcoma Translational Research Program, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Cancer Research, técnicas de investigación::reología::microfluídica [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Càncer - Tractament, Investigative Techniques::Rheology::Microfluidics [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Apoptosi, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Other subheadings::Other subheadings::/drug therapy [Other subheadings], fenómenos fisiológicos celulares::muerte celular::apoptosis [FENÓMENOS Y PROCESOS], Neoplasms [DISEASES], neoplasias [ENFERMEDADES], terapéutica::medicina de precisión [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Oncology, Medicaments - Eficàcia, Medicina personalitzada, Therapeutics::Precision Medicine [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Cell Physiological Phenomena::Cell Death::Apoptosis [PHENOMENA AND PROCESSES]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab868b9a68650a153294b2c6620a9f0cTest
https://doi.org/10.1038/s41698-022-00333-0Test

المؤلفون: Kathleen N. Moore, Alexandra Leary, Dominique Berton, Christina P. Opperman, Maria Del Pilar Estevez-Diz, Laurence Gladieff, Marek Ancukiewicz, Anne-Claire Hardy-Bessard, Frédéric Selle, Isabelle Ray-Coquard, Waldo Ortuzar Feliu, Carlos Rojas, Bradley J. Monk, David M. O'Malley, Ana Oaknin, Carla Rameri Alexandre Silva de Azevedo, Leslie M Randall, Jérôme Alexandre

المساهمون: Institut Català de la Salut, [O'Malley DM] The Ohio State University, James Comprehensive Cancer Center, Columbus, OH, United States. [Oaknin A] Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Monk BJ] Arizona Oncology (US Oncology Network), Creighton University School of Medicine, Phoenix, AZ, United States. [Selle F] Groupe Hospitalier Diaconesses-Croix Saint Simon, Paris, France. [Rojas C] Centro de Investigacion Clinica, Bradford Hill, Santiago, Chile. [Gladieff L] Institut Claudius Regaud-Institut Universitaire du Cancer (IUCT)-Oncopole, Toulouse, France, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Adult, Diarrhea, medicine.medical_specialty, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Uterine Cervical Neoplasms, Phases of clinical research, Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Female::Uterine Neoplasms::Uterine Cervical Neoplasms [DISEASES], Other subheadings::Other subheadings::/drug therapy [Other subheadings], Antibodies, Monoclonal, Humanized, Gastroenterology, Drug Administration Schedule, Coll uterí - Càncer - Tractament, Internal medicine, Clinical endpoint, Humans, Medicine, Infusions, Intravenous, Adverse effect, Immune Checkpoint Inhibitors, Response Evaluation Criteria in Solid Tumors, Aged, Aged, 80 and over, Enterocolitis, Cervical cancer, business.industry, Obstetrics and Gynecology, Immunotherapy, Middle Aged, medicine.disease, Progression-Free Survival, Clinical trial, Oncology, Medicaments - Eficàcia, Avaluació de resultats (Assistència sanitària), Female, Neoplasm Recurrence, Local, medicine.symptom, business, neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales femeninos::neoplasias uterinas::neoplasias del cuello uterino [ENFERMEDADES]

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::305b8fceb47334a9c726d838350b5dd9Test
https://doi.org/10.1016/j.ygyno.2021.08.018Test

المؤلفون: Castellsagué, Jordi, Linder, Marie, Scholle, Oliver, Calingaert, Brian, Bui, Christine, Arana, Alejandro, Laguna, Clara, Gonzalez-Rubio, Francisca, Giner-Soriano, Maria, Roso-Llorach, Albert, Poblador-Plou, Beatriz, Prados-Torres, Alexandra, Perez-Gutthann, Susana

المساهمون: Castellsague J, Arana A, Perez-Gutthan S Epidemiology, RTI Health Solutions, Barcelona, Spain. Poblador-Plou B, Laguna C, Gonzalez-Rubio F, Prados-Torres A Aragon Health Sciences Institute (IACS), IISAragon, Hospital Universitario Miguel Servet,University of Zaragoza, Zaragoza, Spain. Giner-Soriano M, Roso-Llorach A Institut Universitari d'Investigació en Atenció Primària Jordi Gol (IDIAPJGol), Barcelona, Spain. Universitat Autònoma de Barcelona, Cerdanyola del Vallès, Spain. Linder M Centre for Pharmacoepidemiology, Unit of Clinical Epidemiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden. Scholle O Department of Clinical Epidemiology, Leibniz Institute for Prevention Research and Epidemiology—BIPS, Bremen, Germany. Calingaert B, Bui C Epidemiology, RTI Health Solutions, Research Triangle Park, NC, USA, IDIAP Jordi Gol

المصدر: Scientia

مصطلحات موضوعية: Claudicació intermitent - Tractament, Medicaments - Eficàcia, Claudicació intermitent - Estudi de casos, DISEASES::Cardiovascular Diseases::Vascular Diseases::Arterial Occlusive Diseases::Arteriosclerosis::Intermittent Claudication, Other subheadings::Other subheadings::Other subheadings::/drug therapy, PUBLICATION CHARACTERISTICS::Study Characteristics::Comparative Study, ENFERMEDADES::enfermedades cardiovasculares::enfermedades vasculares::arteriopatías oclusivas::arteriosclerosis::claudicación intermitente, Otros calificadores::Otros calificadores::Otros calificadores::/tratamiento farmacológico, CARACTERÍSTICAS DE PUBLICACIONES::características del estudio::estudio comparativo

وصف الملف: application/pdf

العلاقة: Pharmacoepidemiology and Drug Safety;27(9); Castellsague J, Poblador‐Plou B, Giner‐Soriano M, Linder M, Scholle O, Calingaert B, et al. Effectiveness of risk minimization measures for the use of cilostazol in United Kingdom, Spain, Sweden, and Germany. Pharmacoepidemiol Drug Saf. 2018;27(9):953-961.; https://hdl.handle.net/11351/3804Test

الإتاحة: https://doi.org/10.1002/pds.4584Test
https://hdl.handle.net/11351/3804Test

المؤلفون: Ramírez Saco, David

المساهمون: Universitat de Girona. Facultat de Medicina, Castells Cervelló, Xavier, Marcos-Gragera, Rafael

المصدر: Medicina (TFG)
DUGiDocs – Universitat de Girona
instname

مصطلحات موضوعية: Trastorn per dèficit d'atenció amb hiperactivitat, Medicaments -- Eficàcia, Medicaments -- Efectes secundaris, Drugs -- Effectiveness, Attention-deficit hiperactivity disorder, Drugs -- Side effects

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::b2ff67b761e4e05f1de7ba9aabd8510bTest
http://hdl.handle.net/10256/21634Test

المؤلفون: Ramón Teira, Helena Diaz-Cuervo, Filipa Aragão, Manuel Castaño, Alberto Romero, Bernardino Roca, Marta Montero, Maria José Galindo, Maria Jose Muñoz-Sánchez, Nuria Espinosa, Joaquim Peraire, Elisa Martínez, Belén de la Fuente, Pere Domingo, Elisabeth Deig, María Dolores Merino, Paloma Geijo, Vicente Estrada, María Antonia Sepúlveda, Josefina García, Juan Berenguer, Adriá Currán

المساهمون: [Teira R] Service of Internal Medicine, Hospital de Sierrallana, Torrelavega, Spain. [Diaz-Cuervo H] Gilead Sciences, MAOR, London, UK. [Aragão F] Maple Health Group, New York City, NY, USA. NOVA National School of Public Health, Public Health Research Centre, Unversidade NOVA de Lisboa, Lisboa, Portugal. [Castaño M] Hospital Regional Universitario de Málaga, Málaga, Spain. [Romero A] Hospital Universitario de Puerto Real, Puerto Real, Spain. [Roca B] Hospital General de Castellón, Castellón, Spain. [Deig E] Hospital General de Granollers, Granollers, Spain. [Currán A] Vall d’Hebron Hospital Universitari, Barcelona, Spain, Hospital General de Granollers

المصدر: Infectious Diseases and Therapy
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Consejo Superior de Investigaciones Científicas (CSIC)
Scientia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

مصطلحات موضوعية: Microbiology (medical), virosis::infecciones por virus ARN::infecciones por Retroviridae::infecciones por Lentivirus::infecciones por VIH [ENFERMEDADES], Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], HIV, Effectiveness, Other subheadings::Other subheadings::/drug therapy [Other subheadings], Infectious Diseases, Virologic failure, Adverse events, Time to discontinuation, Medicaments - Efectes fisiològics, Medicaments - Eficàcia, VIH (Virus) - Tractament, Virus Diseases::RNA Virus Infections::Retroviridae Infections::Lentivirus Infections::HIV Infections [DISEASES], Two-drug combinations, Triple therapy

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72c9d2be82c5d83c38b512ef95c9cef4Test
https://pubmed.ncbi.nlm.nih.gov/35399147Test

المؤلفون: Seock-Ah Im, Patrick Neven, John Crown, Rosa-Maria Espadero, Noelia Martínez, Yen-Shen Lu, Jonas Bergh, Thomas Bogenrieder, J. Alejandro Pérez-Fidalgo, Peter Schmid, Guy Jerusalem, Laura Schlieker, Serafin Morales, Dennis Chin-Lun Huang, Douglas Adamson, Javier Cortes, Anthony Gonçalves, Keun Seok Lee, Marie-Paule Sablin, Aleix Prat

المساهمون: Queen Mary University of London (QMUL), Institut Curie [Paris], Karolinska University Hospital [Stockholm], Seoul National University Hospital, National Taiwan University Hospital [Taipei], Ramon & Cajal University Hospital, UZ Leuven - campus Gasthuisberg, Hospital of National Cancer Center [Goyang], Hospital Universitario Arnau de Vilanova de Lleida, Biomedical Research Institute [Valencia, Spain] (INCLIVA ), Ninewells Hospital and Medical School [Dundee], Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona (UB), Centre Hospitalier Universitaire de Liège (CHU-Liège), Boehringer Ingelheim Pharma GmbH & Co. KG, St Vincent's University Hospital, Vall d'Hebron Institute of Oncology [Barcelone] (VHIO), Vall d'Hebron University Hospital [Barcelona], Institute of Oncology Prof. Dr. Alexandru Trestioreanu (IOB), Institut Català de la Salut, [Schmid P] Centre for Experimental Cancer Medicine, Barts Cancer Institute, Queen Mary University of London, London, UK. [Sablin MP] Department of Drug Development and Innovation, Institut Curie, Paris, France. [Bergh J] Department of Oncology-Pathology, Karolinska Institutet and Breast Cancer Centre, Cancer Theme, Karolinska University Hospital, Stockholm, Sweden. [Im SA] Department of Internal Medicine, Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea. [Lu YS] Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. [Martínez N] Department of Oncology, Ramon y Cajal University Hospital, Madrid, Spain. [Cortés J] Breast Cancer Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Department of Oncology, IOB Institute of Oncology, Quironsalud Group, Madrid and Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Breast Cancer Research
Breast Cancer Research, 2021, 23 (1), pp.8. ⟨10.1186/s13058-020-01382-8⟩
Breast Cancer Research, Vol 23, Iss 1, Pp 1-11 (2021)
Breast Cancer Research : BCR
Scientia

مصطلحات موضوعية: Oncology, Receptor, ErbB-2, Neoplasms::Neoplasms by Site::Breast Neoplasms [DISEASES], chemistry.chemical_compound, 0302 clinical medicine, Breast cancer, Exemestane, Antineoplastic Combined Chemotherapy Protocols, terapéutica::farmacoterapia::farmacoterapia combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Clinical endpoint, Insulin-like growth factor, Neoplasm Metastasis, Aged, 80 and over, neoplasias::neoplasias por localización::neoplasias de la mama [ENFERMEDADES], 0303 health sciences, education.field_of_study, Hazard ratio, Therapeutics::Drug Therapy::Drug Therapy, Combination [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Disease Management, Middle Aged, Prognosis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Metastatic breast cancer, Treatment Outcome, Receptors, Estrogen, 030220 oncology & carcinogenesis, Female, Receptors, Progesterone, Life Sciences & Biomedicine, Research Article, medicine.drug, Adult, medicine.medical_specialty, Maximum Tolerated Dose, Population, Breast Neoplasms, [SDV.CAN]Life Sciences [q-bio]/Cancer, Antibodies, Monoclonal, Humanized, lcsh:RC254-282, 03 medical and health sciences, Internal medicine, Biomarkers, Tumor, medicine, Hormone receptor-positive, Humans, Xentuzumab, Everolimus, education, Adverse effect, Aged, Neoplasm Staging, 030304 developmental biology, Science & Technology, business.industry, diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], medicine.disease, Androstadienes, chemistry, Mama - Càncer - Tractament, Medicaments - Eficàcia, business, HER2-negative

وصف الملف: application/pdf; Electronic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3fb312f1fe2cc964111c140ba48f774Test
https://hal.science/hal-03630009Test

المؤلفون: Filipa Aragão, Joaquim Peraire, Juan Berenguer, Pere Domingo, Belén de la Fuente, Sophie Marguet, María José Galindo, María Dolores Merino, Vicente Estrada, Fernando Lozano, Josefina Garcia, Ramón Teira, Esteban Ribera, Nadia Abdulghani, Helena Diaz-Cuervo, Bernardino Roca, Maria Jose Muñoz, Marta Montero, Elisa Martínez, M. Antonia Sepúlveda, Alberto Romero, Nuria Espinosa, Elisabeth Deig, Paloma Geijo

المساهمون: Institut Català de la Salut, [Teira R] Hospital de Sierrallana, Torrelavega, Spain. [Diaz-Cuervo H] Gilead Sciences, Medical Affairs, Stockley Park HEOR, Spain. [Aragão F] Maple Health Group, New York, New York, United States of America. NOVA National School of Public Health, Public Health Research Centre, Universidade NOVA de Lisboa, Lisboa, Portugal. [Marguet S] Amaris Consulting, Health Economics and Market Access (HEMA), Levallois-Perret, France. [de la Fuente B] Hospital de Cabueñes, Gijón, Spain. [Muñoz MJ] Hospital de Basurto, Bilbao, Spain. [Ribera E] Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: PLoS ONE
PLoS ONE, Vol 16, Iss 4, p e0249515 (2021)
PLoS One
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Scientia
Plos One
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe

مصطلحات موضوعية: 0301 basic medicine, DOLUTEGRAVIR, RNA viruses, Male, Viral Diseases, HIV Infections, Pathology and Laboratory Medicine, Toxicology, Biochemistry, chemistry.chemical_compound, 0302 clinical medicine, Medical Conditions, ANTIRETROVIRAL THERAPY, Immunodeficiency Viruses, Nucleic Acids, terapéutica::farmacoterapia::farmacoterapia combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Medicine and Health Sciences, Public and Occupational Health, 030212 general & internal medicine, Prospective Studies, INFECTED PATIENTS, Multidisciplinary, Protease Inhibitor Therapy, Hazard ratio, Therapeutics::Drug Therapy::Drug Therapy, Combination [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], HIV diagnosis and management, Standard of Care, Middle Aged, Viral Load, Vaccination and Immunization, AIDS, Drug Combinations, Infectious Diseases, Medical Microbiology, Research Design, Viral Pathogens, Dolutegravir, Cohort, Viruses, Medicine, Reverse Transcriptase Inhibitors, Female, virus::virus ARN::Retroviridae::Lentivirus::Lentivirus de los primates::VIH [ORGANISMOS], Pathogens, Research Article, medicine.medical_specialty, PHASE-3, Clinical Research Design, Anti-HIV Agents, Science, 030106 microbiology, Immunology, Antiretroviral Therapy, Research and Analysis Methods, Microbiology, 03 medical and health sciences, Antiviral Therapy, Internal medicine, Retroviruses, medicine, Humans, Microbial Pathogens, Survival analysis, SUPPRESSION, Retrospective Studies, Toxicity, Proportional hazards model, business.industry, Lentivirus, Organisms, diagnóstico::pronóstico::resultado del tratamiento [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Biology and Life Sciences, HIV, Diagnosis::Prognosis::Treatment Outcome [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Confidence interval, Diagnostic medicine, Discontinuation, Regimen, chemistry, Medicaments - Eficàcia, Viruses::RNA Viruses::Retroviridae::Lentivirus::Lentiviruses, Primate::HIV [ORGANISMS], HIV-1, RNA, Preventive Medicine, Adverse Events, Medicaments - Administració, business, Persones seropositives

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::881d13bfafe5b7088fea060081bd6fd9Test
http://europepmc.org/articles/PMC8031389Test

المؤلفون: Roberto Diaz-Beveridge, Luis Miguel De Sande-González, Antonio López Pousa, Jordi Rubió-Casadevall, Javier Martin-Broto, Pablo Luna, Juan Antonio Carrasco, Claudia M Valverde-Morales, Andres Poveda, Gloria Marquina, María Ángeles Vaz Salgado, Javier Martinez-Trufero, Antonio Gutierrez, Ana De Juan, Juana María Cano, Ibon Gurruchaga-Sotes, Isabel Sevilla, Josefina Cruz-Jurado, Jerónimo Martínez-García, Rosa Alvarez, David S. Moura

المساهمون: Institut Català de la Salut, [Martínez-Trufero J] Javier Martinez-Trufero, Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain. [De Sande-González LM] Medical Oncology Department, Complejo Asistencial Universitario de Leon, Leon, Spain. [Luna P] Medical Oncology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain. [Martin-Broto J] Medical Oncology Department, Hospital Universitario Virgen del Rocio, Instituto de Biomedicina de Sevilla (IBiS, CSIC, US, HUVR), Sevilla, Spain. [Álvarez R] Medical Oncology Department, Hospital Universitario Gregorio Marañon, Madrid, Spain. [Marquina G] Medical Oncology Department, Hospital Universitario Clinico San Carlos, Madrid, Spain. [Valverde-Morales CM] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, [Martínez-Trufero,J, Gurruchaga-Sotes,I] Javier Martinez-Trufero, Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain. [De Sande-González,LM] Medical Oncology Department, Complejo Asistencial Universitario de Leon, Leon, Spain. [Luna,P] Medical Oncology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain. [Martin-Broto,J] Medical Oncology Department, Hospital Universitario Virgen del Rocio, Instituto de Biomedicina de Sevilla (IBiS, CSIC, US, HUVR), Sevilla, Spain. [Álvarez,R] Medical Oncology Department, Hospital Universitario Gregorio Marañon, Madrid, Spain. [Marquina,G] Medical Oncology Department, Hospital Universitario Clinico San Carlos, Madrid, Spain. [Diaz-Beveridge,R] Medical Oncology Department, Hospital Politécnico La Fe, Valencia, Spain. [Poveda,A] Medical Oncology Department, Instituto Valenciano de Oncologia, Valencia, Spain. [Cano,JM] Medical Oncology Department, Hospital General de Ciudad Real, Ciudad Real, Spain. [Cruz-Jurado,J] Medical Oncology Department, Hospital Universitario Canarias, Santa Cruz de Tenerife, Spain. [López Pousa,A] Medical Oncology Department, Hospital Universitario Santa Creu i Sant Pau, Barcelona, Spain. [Vaz Salgado,MA] Medical Oncology Department, Hospital Universitario Ramon y Cajal, RYCIS, CIBERONC, Madrid, Spain. [Valverde-Morales,C] Medical Oncology Department, Hospital Universitario Vall D’Hebron, Barcelona, Spain. [Sevilla,I] Investigación Clínica y Traslacional en Cáncer, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Medical Oncology Department, Hospitales Universitarios Regional y Virgen de la Victoria de Málaga, Malaga, Spain. [Martínez-García,J] Medical Oncology Department, Hospital Virgen de la Arrixaca, Murcia, Spain. [Rubio-Casadevall,J] Medical Oncology Department, Instituto Catalan Oncologia, Girona, Spain. [De Juan,A] Medical Oncology Department, Hospital Marqués de Valdecilla, Santander, Spain. [Carrasco,JA] Medical Oncology Department, Hospital Alvaro Cunqueiro, Vigo, Spain. [Moura,DS] Instituto de Biomedicina de Sevilla (IBiS, CSIC, US, HUVR), Sevilla, Spain. [Gutiérrez,A] Hematology Department, Hospital Universitario Son Espases, 07010 Palma de Mallorca, Spain., This research was funded by the Spanish Group for Research on Sarcoma (grant number: NA) and partially by PharmaMar. PharmaMar S.A. did not have any role in study design, or in collection, analysis and interpretation of data.

المصدر: Cancers
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Cancers, Vol 13, Iss 792, p 792 (2021)
Scientia
Volume 13
Issue 4
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau

مصطلحات موضوعية: 0301 basic medicine, Oncology, Advanced soft tissue sarcomas, Cancer Research, Multivariate analysis, sarcoma, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Epidemiologic Study Characteristics as Topic::Epidemiologic Studies::Case-Control Studies::Retrospective Studies [Medical Subject Headings], Trabectedina, España, Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Sarcoma [Medical Subject Headings], Other subheadings::Other subheadings::/drug therapy [Other subheadings], Metastasis, Prognostic score, Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings], 0302 clinical medicine, Trabectedin, Tumors de parts toves, Soft tissue sarcoma, Pronóstico, Soft tissue, Liposarcoma, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, prognostic score, GEISTRA, L-sarcoma, growth modulation index, prognostic score, sarcoma, trabectedin, 030220 oncology & carcinogenesis, trabectedin, Sarcoma, L-sarcoma, medicine.drug, medicine.medical_specialty, Chemicals and Drugs::Organic Chemicals::Sulfur Compounds::Thiazoles::Thiamine::Thiamine Triphosphate [Medical Subject Headings], GEISTRA, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Epidemiologic Methods::Statistics as Topic::Analysis of Variance::Multivariate Analysis [Medical Subject Headings], Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Neoplasms::Neoplasms by Site::Soft Tissue Neoplasms [DISEASES], epidemiología y bioestadística::epidemiología::usos de la epidemiología::efectividad [SALUD PÚBLICA], lcsh:RC254-282, Article, Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Sarcoma::Leiomyosarcoma [Medical Subject Headings], 03 medical and health sciences, Internal medicine, medicine, Diseases::Neoplasms::Neoplasms by Histologic Type::Neoplasms, Connective and Soft Tissue::Sarcoma::Liposarcoma [Medical Subject Headings], neoplasias::neoplasias por localización::neoplasias de los tejidos blandos [ENFERMEDADES], Geographical Locations::Geographic Locations::Europe::Spain [Medical Subject Headings], business.industry, Retrospective cohort study, medicine.disease, 030104 developmental biology, Spain, Medicaments - Eficàcia, Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis [Medical Subject Headings], Epidemiology and Biostatistics::Epidemiology::Uses of Epidemiology::Effectiveness [PUBLIC HEALTH], Leiomiosarcoma, business, growth modulation index

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7ae189020c1b9820dc01b3e6d0041c2Test
https://hdl.handle.net/10668/17307Test